CFLAR and sarcoma: Knock down of ATM, AMPKα, ULK1, Beclin1 or ATG5 also protected sarcoma cells from drug combination-induced killing, with knock down of Beclin1 or ATG5 apparently more protective than over-expression of BCL-XL, FLIP-s and dominant negative caspase 9.